You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Express Scripts
McKinsey
Boehringer Ingelheim
Harvard Business School

Last Updated: May 11, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BARICITINIB

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Baricitinib

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01185353 A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy Completed Incyte Corporation Phase 2 2010-10-01 The purpose of this trial is to evaluate the safety and efficacy of LY3009104 in participants with Rheumatoid Arthritis (RA).
NCT01185353 A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy Completed Eli Lilly and Company Phase 2 2010-10-01 The purpose of this trial is to evaluate the safety and efficacy of LY3009104 in participants with Rheumatoid Arthritis (RA).
NCT01683409 A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease Completed Incyte Corporation Phase 2 2012-08-01 This is a dose ranging study to evaluate the safety and efficacy of baricitinib in the treatment of participants with mild to moderate diabetic kidney disease.
NCT01683409 A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease Completed Eli Lilly and Company Phase 2 2012-08-01 This is a dose ranging study to evaluate the safety and efficacy of baricitinib in the treatment of participants with mild to moderate diabetic kidney disease.
NCT01710358 A Study in Moderate to Severe Rheumatoid Arthritis Completed Eli Lilly and Company Phase 3 2012-10-01 The purpose of this study is to determine whether baricitinib is superior to placebo in the treatment of participants with moderately to severely active Rheumatoid Arthritis (RA) who have had an inadequate response to methotrexate (MTX) treatment.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Baricitinib

Condition Name

Condition Name for Baricitinib
Intervention Trials
Healthy Volunteers 10
Rheumatoid Arthritis 10
Atopic Dermatitis 9
COVID-19 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Baricitinib
Intervention Trials
Arthritis 14
Arthritis, Rheumatoid 11
Dermatitis 10
Dermatitis, Atopic 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Baricitinib

Trials by Country

Trials by Country for Baricitinib
Location Trials
United States 358
Japan 58
United Kingdom 56
Germany 46
Spain 34
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Baricitinib
Location Trials
California 20
Florida 19
Texas 18
Pennsylvania 16
New York 16
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Baricitinib

Clinical Trial Phase

Clinical Trial Phase for Baricitinib
Clinical Trial Phase Trials
Phase 4 3
Phase 3 29
Phase 2/Phase 3 4
[disabled in preview] 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Baricitinib
Clinical Trial Phase Trials
Not yet recruiting 28
Completed 18
Recruiting 17
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Baricitinib

Sponsor Name

Sponsor Name for Baricitinib
Sponsor Trials
Eli Lilly and Company 49
Incyte Corporation 17
National Institute of Allergy and Infectious Diseases (NIAID) 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Baricitinib
Sponsor Trials
Industry 67
Other 25
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Baxter
AstraZeneca
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.